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Introduction
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Skin organ culture models in veterinary medicine started with the work of Kondo and colleagues who reported on the maintenance of normal rabbit ear skin explants for up to 12 weeks and its pharmacological modulation (Kondo et al., 1990) . More recently, a skin organ culture model from Gottingen minipigs has also been established (Dame et al., 2008) . Although canine keratinocyte cultures have been developed (Kimura et al., 2012; Shibata et al., 2010) and organotypic models are available in dogs (Cerrato et al., 2012; Kobayashi et al., 2013; Serra et al., 2007; Yagihara et al., 2011) , skin organ culture has not yet been attempted in this species.
Cell cultures are largely used in toxicological studies and cancer research, but still they are insufficient to investigate skin morpho-physiology, epidermal barrier impairment or epithelialmesenchymal interaction, due to their monocellular composition. Organotypic models overcome this limitation. Unlike the traditional "on-a-plastic" systems, these models reproduce the threedimensional stratified space within which skin cells normally live and function, nonetheless they only partly recapitulate normal microanatomy and physiology of the skin (Oh et al., 2013) .
Skin organ culture methods may thus offer unique opportunities, not only to overcome the concerns surrounding the use of animals for biomedical research, but also to study drugs in a biologically relevant environment with the same three-dimensional cell-cell and cell-matrix contacts and communications as are present in intact tissue.
Although in an organ culture model serum was reported to enhance general viability of the epidermis and increase the formation of new stratum corneum (Tammi and Jansen, 1980) , its presence was also considered a limitation. This is due to a variable and hardly definable medium composition and the possible interaction of serum molecules deriving both from a different species (i.e. canine skin cultured with bovine serum) and different developmental stage (fetal serum used on adult skin) .
With this in mind, we developed a serum-free canine model of skin organ culture and investigated the pharmacological modulation thereof. Epidermal growth factor (EGF) and dexamethasone (DMS) were used, this latter agent known to inhibit the effect of the first (Kondo et al., 1990) . Since the discovery of EGF (Cohen, 1962) its mitogenic activity has been described in several systems (Zeng and Harris, 2014) . Now it is classified as the prototype of the group I EGF family that also includes other growth factors that share the ability to bind the EGF receptor, activate its intrinsic tyrosine kinase activity, and couple the receptor to downstream signaling pathways that are involved in cell proliferation, differentiation, survival, or motility (Carpenter, 1987; Zeineldin and Hudson, 2006; Zeng and Harris, 2014) . Keratinocyte proliferation as well as terminal differentiation has been shown to be mediated by the EGF receptor, since its inhibition resulted in growth arrest and terminal differentiation (Peus et al., 1997) .
In the study by Kondo and colleagues, EGF was used to stimulate keratinocyte proliferation in a rabbit model of skin organ culture, and DMS was found to inhibit this effect (Kondo et al., 1990) . The intracellular mechanisms that regulate such interaction were unknown at that time, while today, they have been more thoroughly described and seem to depend primarily on the extracellular signal-regulated kinase (ERK) pathway (Luo et al., 2007) and glucocorticoid receptors (Kimura et al., 2011) .
Here we present a 14-day setup of a serum-free model of canine skin organ culture and its pharmacological modulation with EGF and DMS.
Materials and methods
Animals and sample collection
Normal skin was obtained from five client-owned dogs subjected to surgical procedures unrelated to dermatological conditions (removal of mammary neoplastic lesions). A written informed consent was obtained from each dog's owner prior to surgery. Before anesthesia with propofol 4 mg/kg IV and isoflurane 2% in oxygen, hair was clipped and the surgical site aseptically prepared. Skin to be cultured was collected at the periphery of the surgical site in order to avoid atrophic changes due to the presence of either the tumor or lymph node enlargement.
Set-up of the dog skin organ culture for 14 days
During the surgical procedure, skin strips were collected and promptly immersed in the isolation medium (99% Williams' E Medium-l-glutamine free supplemented with 1% antibiotic antimycotic solution containing 10,000 IU penicillin, 10 mg streptomycin and 25 g amphotericin B per mL). The sample was kept at 4 • C until the establishment of the organ culture (within 2 h of sampling).
To perform skin organ cultures, full-thickness 4 mm skin biopsy punches were collected from the isolated skin after mechanical removal of excess of subcutaneous fat by using a surgical scalpel. Three skin biopsies from each dog were immersed in 10% buffered formalin solution (pH 7.4) and regarded as Day 0 samples. Cultures were established from each dog in triplicate (three biopsies per time-point); skin biopsies were placed into 6-well plate Petri dish containing Williams' E medium supplemented with 1% 10000 IU/ml penicillin-10 mg/ml streptomycin, 0.1% 10 g/ml insulin, 0.02% 10 ng/ml hydrocortisone and 1% 200 mM l-glutamine. All reagents were commercially obtained (Williams' E Medium Cat. N • W4128. Antibiotic antimycotic solution Cat. N • A5955. Penicillin-streptomycin solution cat N • P4333; Insulin cat N • I9278; Hydrocortisone cat N • H0135; l-glutamine cat N • G7513; Sigma Aldrich S.R.L. Milan, IT).
Medium was replaced after 24 h and then at 2-day intervals. Skin samples were kept at 37 • C in a humidified incubator with 5% CO 2 for 14 days. Three cultured biopsies per each selected time-point (day 1, 4, 7, 14) were collected and fixed in 10% buffered formalin solution (pH 7.4) and routinely processed for paraffin embedding, thus allowing a time-course for the evolution of epidermal, dermal and adnexal conditions during culture. The following histological parameters were then assessed: morphological features, epidermal thickness, keratinocyte proliferation and epidermal differentiation.
Epidermal growth factor and dexamethasone effect on canine cultured skin
The effect of EGF supplementation was evaluated on skin obtained from three different dogs. DMS was used to inhibit EGF effects. Biopsy triplicates were treated for three days -from day 2 to day 5 - (Kondo et al., 1990 ) with either vehicle (culture medium), or 10 or 20 ng/mL EGF (epidermal growth factor human; cat N • E9644 Sigma Aldrich S.R.L. Milan, IT). A second set of triplicates was treated with either DMS 10 g/mL alone, or EGF 10 ng/mL-DMS 10 g/mL or EGF 20 ng/mL-DMS 10 g/mL. The following parameters were assessed according to this experimental set up: morphological features, epidermal thickness, keratinocyte proliferation, length of epithelial tongues forming at the periphery of the cultured biopsy and epidermal differentiation.
Morphological features
Morphological features were evaluated on H&E stained 5 m sections. The presence of culture-induced changes was qualitatively evaluated on epidermis, dermis and adnexal structures.
Epidermal thickness
Epidermal thickness was measured on 20, 400× captured fields per time point, by manually tracing 16 segments at regular intervals per captured field with NIS-Elements Br Microscope Imaging Software (NIS-Elements Br Microscope Imaging Software. Nikon Instruments, Calenzano, Italy). Segments were perpendicular to the basement membrane and extended from the germinative layer to the beginning of the stratum corneum.
Keratinocyte proliferation
Ki67 immunostaining was performed to evaluate keratinocyte proliferation. Briefly, superfrost-Plus mounted sections were deparaffinized and rehydrated. Epitope retrieval was carried out at 120 • C in a pressure cooker for 3 min with a Tris/EDTA buffer pH 9.0. Quenching of endogenous peroxidases was carried out by incubation with 1% H 2 O 2 in phosphate buffer 0.1 M pH 7.4 (PBS), 5 min, at room temperature (RT). Non-specific binding was prevented by incubation of slides with 5% normal goat serum (Normal goat serum. Cat N • s-1000; Vector Labs, Burlingame, CA, USA) for 1 h at RT. Slides were thus incubated with the mouse monoclonal anti-Ki67 primary antibody (Monoclonal anti-Ki67 primary antibody. Cat N • sc-101861; Santa Cruz Biotechnology, Inc. TX, USA) 1:200 in PBS overnight at 4 • C. Subsequently they were rinsed in PBS, 3× 10 min, followed by incubation with a biotinylated goat anti-mouse immunoglobulin (Goat anti-mouse biotinylated antibody. Cat N • BA-9200; Vector Labs, Burlingame, CA, USA), diluted 1:300 in PBS. Sections were again rinsed in PBS, for 3× 10 min. Staining was visualized by incubating the sections in diaminobenzidine solution (Diaminobenzidine. Cat N • sk-4105; Vector Labs, Burlingame, CA, USA). Sections were then dehydrated, cleared and mounted with a permanent mounting medium. Five 250× fields were photographed per time point per animal and Ki67-positive cells were counted; counts were expressed as percentage of basal cells.
Length of peripheral epithelial tongues
Cultured skin showed the formation of epithelial "tongues" at the periphery of the biopsy samples. Measurements were obtained from all triplicates at each time point and averaged among the donor dogs (n = 3).
Epidermal differentiation
To assess epidermal differentiation, cytokeratin 10, cytokeratin 14 and loricrin were immunolocalised. Indirect immunofluorescence was performed as follows: superfrost-Plus mounted sections were deparaffinized and rehydrated; epitope retrieval was carried out at 120 • C in a pressure cooker for 3 min with a Tris/EDTA buffer pH 9.0. Non-specific binding was prevented by incubation of slides with PBS +2% BSA (Bovine serum albumin. Cat. N • SP-5050; Vector Labs, Burlingame, CA, USA) (45 min at RT). Slides were incubated overnight at 4 • C with either a cocktail of the mouse monoclonal anti cytokeratin 10 (Anti-cytokeratin 10 monoclonal antibody. Cat N • ab9026; Abcam plc, Cambridge, UK) and the rabbit polyclonal anti loricrin (Anti-loricrin polyclonal antibody. Cat N • ab24722; Abcam plc, Cambridge, CB4 0FL, UK), or the mouse monoclonal anti cytokeratin 14 (Anti-cytokeratin 14 monoclonal antibody. Cat N • ab7800; Abcam plc, Cambridge, CB4 0FL, UK) or the rabbit polyclonal anti loricrin (Anti-loricrin polyclonal antibody. Cat N • ab24722; Abcam plc, Cambridge, CB4 0FL, UK) diluted in PBS +1% BSA. Subsequently, they were rinsed in PBS, 3× 10 min, followed by incubation with: fluorescein antimouse (Fluorescein anti-mouse antibody. Cat N • FI-2000; Vector Labs, Burlingame, CA, USA) for cytokeratin 14 and cytokeratin 10; fluorescein anti-rabbit (Fluorescein anti-rabbit antibody, Cat N • FI-1000; Vector Labs, Burlingame, CA, USA) for loricrin. Slides were then mounted with Vectashield mounting medium with 4 ,6-diamidino-2-phenylindole (DAPI) for nuclear counterstaining (Vectashield mounting medium with DAPI. Cat N • H-1500; Vector Labs, Burlingame, CA, USA).
Statistical analysis
All measures were averaged and analyzed with GraphPad Prism for Windows (GraphPad Prism version 5.00 for Windows. GraphPad Software, San Diego, CA, USA). One-way ANOVA in conjunction with Bonferroni's multiple comparison test was used for statistical comparisons of the examined parameters per each time point. Data reported in the results section are expressed as mean ± standard deviation (SD).
Results
3.1. Set-up of the dog skin organ culture for 14 days
Morphological features
In the epidermis, keratinocytes were stratified into two-to-four nucleated cell layers throughout the entire study period. They appeared as normal, viable epithelial cells, however starting from day 7 of culture, occasional scattered eosinophilic shrunken cells, likely apoptotic cells, were observed in the basal and suprabasal layers. Multifocally distributed, basophilic cytoplasmic granules resembling keratohyaline granules were observed in the subcorneal (i.e. granular) layer until the end of the study. A few brownish to black dots, attributable to melanin pigment granules, were present in both the cytoplasm of a few keratinocytes and aggregated in scattered melanocytes along the basal membrane. Moreover, epidermis was covered by a wavy cornified layer made of loose orthokeratotic keratin.
Dermis remained structurally intact throughout the entire study period and showed normally arranged collagen, grouped in thin bundles in the uppermost layer of the dermis and in larger bundles in the underlying portions. The superficial, medium and periadnexal vascular plexuses were well represented throughout all the duration of the experiment. Perivascular aspecific mononuclear cells were detected in all samples until day 14, among these mast cells were also recognized for their morphology.
Hair follicles were well-preserved at day 0 and they displayed normal cycling morphology; scattered apoptotic figures of the matrical cells as well as swelling and degeneration of the follicle wall cells were seen from day 4. Sebaceous glands were composed of preserved well-differentiated mature sebocytes until the end of the study while a few necrotic changes were seen in their reserve compartment starting on day 7.
The epithelial cells of sweat glands were detached from their basal lamina starting on day 4. Arrector pili muscles were wellpreserved throughout the study period.
Epidermal thickness and keratinocyte proliferation
Epidermal thickness was measured at days 0, 1, 7 and 14. Values, expressed in microns, were 17.67 ± 6.50 at D0, 17.66 ± 7.07 at D1, 17.19 ± 5.54 at D7 and 16.88 ± 4.72 at D14. Thickness at various time points was not statistically different from D0. Representative images are presented in Fig. 1 . Keratinocyte proliferation was assessed by Ki67 immunostaining and cell counts were expressed as percentage of basal cells; the following values were calculated: 8.50 ± 6.50 at D0, 3.93 ± 4.69 at D1, 4.05 ± 5.97 at D4 and 0.39 ± 1.11 at D7. Ki67-immunoreactive cells were not observed at D14 of culture. Time-dependent decrease in cell proliferation was statistically significant at both D7 and D14 (p < 0.05). Most of the proliferating keratinocytes were located at the periphery of the biopsy samples where a tongue of newly formed epithelium was present.
Epidermal differentiation
Cytokeratin 10, cytokeratin 14 and loricrin were immunolocalised at D1, D7 and D14 of culture.
At D1 the double immunofluorescence staining for cytokeratin 10 and loricrin showed a normal skin pattern (Fig. 2a) with loricrin confined to the granular layer of epidermis and cytokeratin 10 present in all the suprabasal, non-keratinized layers. At the following time points, both proteins were present, even though the granular layer identified by loricrin was not continuous (Fig. 2b, c) .
Cytokeratin 14 maintained the same pattern from D1 to D14, staining the basal and suprabasal layers of epidermis (Fig. 2d-f) . 3.2. Epidermal growth factor and dexamethasone effect on canine cultured skin 3.2.1. Morphological features EGF-treated cultures showed normal stratification of the epidermis; epidermal hyperplasia was visible at the higher dose (20 ng/mL). Morphological figures resembling either apoptosis or pyknosis were not observed. The basal layer showed the following treatment-associated changes: occasional mitotic figures and a minimal wavy appearance of the epidermis-to-dermis interface (i.e. basement membrane). The wavy appearance of the basement membrane was not rescued by DMS. Focal parakeratosis was very seldom observed, was not associated with any of the treatments and graded minimal when present. 
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*** p < 0.001 versus vehicle.
• • • p < 0.001 versus EGF 10 g/mL. § p < 0.05 versus EGF 20 g/mL. § § § p < 0.001 versus EGF 20 g/mL.
Epidermal thickness and keratinocyte proliferation
At the end of the three-day supplementation (D2-D5), EGF induced a statistically significant increase in epidermal thickness and keratinocyte proliferation. Both responses were significantly counteracted by DMS, as detailed below (data are summarized in Table 1 ).
Epidermal thickness values (in microns) at the end of treatment (D5) were: 22.93 ± 9.16 for Vehicle, 26.37 ± 14.05 for EGF 10 ng/mL, 26.69 ± 14.25 for EGF 20 ng/mL, 24.05 ± 10.64 for DMS alone, 23.13 ± 14.05 for DMS supplemented with EGF 10 ng/mL and 23.26 ± 11.15 for DMS supplemented with EGF 20 ng/mL. Both doses of EGF significantly induced an increase in epidermal thickness and DMS was able to rescue EGF effect (p < 0.0001).
Ki 67 values were: 4.78 ± 0.95 for Vehicle, 5.61 ± 0.33 for EGF 10 ng/mL, 8.44 ± 0.40 for EGF 20 ng/mL, 3.82 ± 0.16 for DMS alone, 3.61 ± 1.27 for DMS supplemented with EGF 10 ng/mL and 4.66 ± 0.29 for DMS supplemented with EGF 20 ng/mL (expressed as percent of basal cells).
Bonferroni's multiple comparison test showed a significant increase of cell proliferation with EGF 20 ng/mL that was inhibited by DMS (p < 0.05). Most of the proliferating keratinocytes were located at the periphery of the biopsy samples where a tongue of newly formed epithelium was always present. Representative images are presented in Fig. 3. 
Length of peripheral epithelial tongues
At the end of the three-day treatment, the presence of epithelial tongues was detected in all samples examined. Epithelial tongue length values (expressed in m) were the following: 310.58 ± 140.68 for Vehicle, 459.44 ± 205.42 for EGF 10 ng/mL, 487.34 ± 301.3 for EGF 20 ng/mL, 325.14 ± 117.74 for DMS alone, 518.22 ± 309.35 for DMS supplemented with EGF 10 ng/mL and 703.20 ± 525.40 for DMS supplemented with EGF 20 ng/mL. EGF supplementation resulted in a dose-dependent increase in the length of epithelial tongues that showed statistical significance at the higher tested dose (20 ng/mL; p < 0.05). DMS alone did not induce changes in epithelial tongue length while DMS supplementation of EGF treated samples resulted in a further increase in the length of epithelial tongues: both doses of EGF (10 and 20 ng/mL) supplemented with DMS (10 g/mL) were statistically different from vehicle (p < 0.05 and p < 0.001 respectively). Representative images are presented in Fig. 3. 
Epidermal differentiation
Cytokeratin 10 (red staining in Fig. 4 ) was recorded in the suprabasal layers of epidermis in untreated and treated samples; the same staining pattern was thus maintained with all treatments but the basal unstained portion of epidermis was composed of twoto-three lines of cells instead of one in samples treated with EGF at 20 ng/mL. Cytokeratin 14 was present in basal and most suprabasal epidermal layers, its staining pattern did not change with treatments (not shown) and was comparable to that shown in Fig. 2 .
Loricrin immunoreactivity (green staining in Fig. 4 ) was visible in the granular layer of epidermis, was focally discontinuous and its distribution did not change in response to treatment.
In skin epithelial tongues, K10 immunostaining was visible in samples treated with vehicle ( Fig. 5a ) and disappeared in response to all other treatments. Loricrin immunostaining was detected either in the granular layer (vehicle, Fig. 5a ), or in all suprabasal layers (EGF 10 ng/mL; EGF 20 ng/mL; DMS 10 g/mL, Fig. 5b, d, g ) or in all epithelial tongue keratinocytes (DMS 10 g/mL-EGF 10 ng/mL; DMS 10 g/mL-EGF 20 ng/mL; Fig. 5e, h) .
K14 was always present and stained all epithelial tongue keratinocytes (Fig. 5c, f, i) independently of the treatments.
Discussion
Here we report the establishment of a serum-free culture of full-thickness canine skin samples for a 14-day duration and the pharmacologic modulation thereof, using EGF and DMS as stimuli. Considering that serum-free media are commonly used for human skin cultures with good results (de Jesus Ribeiro et al., 2005; Kleszczynski and Fischer, 2012; , we omitted the use of serum in our model, to avoid the presence of uncontrolled factors.
In the present free-serum model, aside from rare apoptotic figures and pycnotic nuclei apparent after 7 days in culture, but which did not increase by day 14, the epidermal compartment showed a physiologic morphology characteristic of the dog with neither severely degenerative nor necrotic changes developing over the duration of the study. Pyknosis is reported to be a sensitive indicator for low level tissue damage (Tammi et al., 1979) , thus the few pyknotic nuclei observed during culture might be indicative of cells having suffered from ischemia.
When examining keratinocyte proliferation, we observed that the majority of Ki67 immunopositive cells were located at the periphery of the biopsy samples, where a tongue of newly formed epithelium was always present. This finding has already been demonstrated in frog and human organ culture model (Meier et al., 2013) and may represent a useful tool for wound healing studies focused to the re-epithelialisation process. Moreover, we found a statistically significant decrease in keratinocyte proliferation at D7 and D14, this latter time-point completely lacking Ki67-stained cells. Previous studies on human full-thickness skin organ culture model reported conflicting data on keratinocyte proliferation: one study showed Ki67-positive cells up to 72 h of culture time, followed by a substantial increase in cell damage/apoptosis (Kleszczynski and Fischer, 2012) ; conversely, a second report detected more proliferating cells than apoptotic cells up to day 5 of culture . While the aforementioned studies did not analyze early time points (such as D1), values of Ki67-positive cells reported by Lu and colleagues at D5 (i.e. 6% proliferating cells) are comparable to our findings at D4 . Various factors might be responsible for the differences observed between the study presented herein and previous ones, such as a speciesrelated difference in epidermal anatomy (e.g., human skin is much more stratified than the canine one). Also, different investigative methods to assess proliferation/apoptosis balance and different culture conditions are to be considered.
While epidermal thickness is undoubtedly related to the number of proliferating keratinocytes, we did not find statistically significant differences when considering the epidermal thickness at different time points: this might relate to the absence of exfoliation the skin normally undergoes in vivo.
As shown in Fig. 2 we then investigated the presence of cytoskeletal markers widely used to assess the physiological differentiation occurring in epidermis, from basal to corneal keratinocytes (Jensen et al., 2007; Kobayashi et al., 2013) . K10 always stained the suprabasal keratinocytes and this is in accordance with its known feature of late differentiation marker (Bernerd et al., 1992; Borowiec et al., 2013) , analogously loricrin was observed in the uppermost layer and is reported as a terminally differentiating structural protein as well as major component of the cornified envelope (Nithya et al., 2015) . In the study samples, the presence of loricrin confirmed a physiological state of epidermis (normally differentiating keratinocytes) at D1 of culture while starting from D7 and similarly at D14, the loricrin-marked stratum was not continuous. This might identify an impairment of the epidermal barrier, since loricrin enhances the protective function of the corneocytes in terminally differentiated keratinocytes (Jarnik et al., 2002) .
In contrast, K14 immunostaining pattern did not change at different time points and stained differentiating keratinocytes of the basal and most of the suprabasal layers. Similar results were reported in a study developing a human skin substitute until day 14 (Castagnoli et al., 2010) and in a canine three-dimensional skin equivalent model (Kobayashi et al., 2013) . It is known that in normal interfollicular epidermis, progenitor basal cells express K14 (Porter et al., 2000) and that upon commitment to differentiation, keratinocytes rapidly turn on the expression of K1-K10 (Woodcock-Mitchell et al., 1982) switching off K5-K14 gene transcription. However, the previously expressed proteins still persist (Fuchs, 1995) and might thus be present in suprabasal layers, as was found in the model described herein.
To test the possibility of using the model presented herein as a tool for drug discovery/development, we hypothesized that it could be pharmacologically modulated; i.e. DMS would counteract the effects induced by EGF, as reported (Kondo et al., 1990) . We observed organ-cultured skin treated with EGF to show changes associated with hyperplasia, like the evidence of scattered mitotic figures. The increase in epidermal thickness observed with both EGF doses was rescued by DMS supplementation as reported in the aforementioned study performed on rabbit skin organ culture by Kondo and colleagues (Kondo et al., 1990) . The proliferation induced by EGF was also documented by keratinocyte Ki67 immunostaining: as was the case for epidermal thickness, a significant increase was observed using both doses of EGF. The increase in cell proliferation with EGF 20 ng/mL resulted in a thicker basal unstained portion of epidermis (two to three layers of keratinocytes instead of one) when immunostained for K10. This latter finding indicates that the observed hyperplastic change was due to a greater presence of undifferentiated layers.
The inhibitory effect of DMS on EGF was not observed on the length of epithelial tongues: in fact, EGF-induced epithelial tongue formation was potentiated by DMS supplementing. If epithelial tongue formation is considered an indicator of "reepithelialization", this finding was unexpected, since DMS and all glucocorticoids are commonly reported to function as inhibitors of wound healing via global anti-inflammatory effects and suppression of cellular wound responses, including fibroblast proliferation and collagen synthesis (Guo and DiPietro, 2010) . Actually, a study demonstrated that glucocorticoids can block EGF-mediated migration by repressing transcription of K6/K16 , keratins known to be associated with hyper-proliferation and malignant transformation (Karantza, 2011; Yoshikawa et al., 1998) . However, it was reported that the hyper-proliferative epidermis at the wound edge (comparable to the periphery of the biopsy sample in our model) is a result of c-myc activation and overexpression (Pastar et al., 2014; Stojadinovic et al., 2005) and glucocorticoids are demonstrated to induce c-myc . Lastly, topical application of low-dosage corticosteroid treatment to chronic wounds has been found to accelerate wound healing (Hofman et al., 2007) . Thus, more investigations are needed to better understand this finding.
An even more unexpected observation was that above a thin basal layer of keratinocytes, epithelial tongues were found to express K10 only in the control sample while both EGF alone and EGF supplemented by DMS induced the presence of loricrinpositive epithelial tongues. This result is particularly controversial since loricrin is a terminally differentiating protein (Nithya et al., 2015) that was not expected to be observed in a migrating epithelium. Our findings may be, however, corroborated by the observations of Laplante and colleagues (Laplante et al., 2001) made in a human model of tissue-engineered reconstructed skin: they showed that suprabasal layers of epidermis (made of differentiated keratinocytes) are "pushed" toward the wound center by a force (likely coming from the adjacent unwounded epidermis) that originates from the mitotic pressure. In this regard, it is of note that in our samples Ki67-stained cells were often concentrated at the periphery of the biopsy samples, right beside the migrating epithelium and not within it. This process (displacement of already cornified keratinocytes) had been described as an early reconstitution of the epidermal barrier, before the entire differentiation process occurs (Laplante et al., 2001 ).
In conclusion this canine skin organ culture method can be used as a valuable research tool for gaining new insights into histological and biological features of dog skin, and better understanding of the etiopathological mechanism underlying particular skin diseases. More importantly, it allows studying the canine skin response to test agents during naturally-and experimentally-induced skin disorders, and might provide evidence on drug absorption. In particular, our findings demonstrate the possibility to use this fullthickness canine skin organ culture model for the study of new chemical entities in the field of wound re-epithelialisation and keratinization disorders, all of which have high prevalence and severe impact on canine quality of life and often require pharmacological treatments.
